Barclays
NUTX

Barclays’s Nutex Health NUTX Stock Holding History

Barclays’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.7M Buy
17,887
+9,824
+122% +$1.2M ﹤0.01% 2451
2025
Q4 		$1.33M Buy
8,063
+3,155
+64% +$418K ﹤0.01% 3239
2025
Q3 		$507K Sell
4,908
-1,770
-27% -$174K ﹤0.01% 3803
2025
Q2 		$831K Buy
+6,678
New +$863K ﹤0.01% 3460
2023
Q4 		– Sell
-444
Closed -$13.5K – 5314
2023
Q3 		$13.5K Buy
444
+14
+3% +$675 ﹤0.01% 4253
2023
Q2 		$27.2K Sell
430
-423
-50% -$36.3K ﹤0.01% 4070
2023
Q1 		$129K Buy
853
+404
+90% +$81.8K ﹤0.01% 4046
2022
Q4 		$128K Buy
449
+438
+3,982% +$84.1K ﹤0.01% 4092
2022
Q3 		$2K Sell
11
-2
-15% -$848 ﹤0.01% 4635
2022
Q2 		$6K Buy
+13
New +$15.3K ﹤0.01% 4751

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Barclays's NUTX Position: Q1 2026 in Review

Barclays increased its Nutex Health (NUTX) stake by 122% in Q1 2026, buying an estimated $1.2M and bringing the position to 17,887 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2451.

Barclays first reported a position in NUTX in Q2 2022 and has held it in 10 quarters since. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Barclays held 17,887 shares of Nutex Health worth $1.7M as of Q1 2026.
  • Barclays bought 9,824 Nutex Health shares in Q1 2026, an estimated $1.2M.
  • Nutex Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2451 holding.
  • Barclays first reported a position in Nutex Health in Q2 2022 and has held it in 10 quarters since.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.